PHARMANUT
ActiveSummary
PHARMANUT has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €233k and a net result of €45k. Equity is growing by ~42.4% per year across the filed fiscal years. Its solvency ranks better than 26% of 31694 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
71
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability75▲+1
Solvency49▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity tight (current ratio 1.25 against 0.98 in 2024; short-term debt: 9.3% and cash: 2% of total assets), and 75.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
24.3%
Return on assets
4.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
22 d early
2024
34 d early
2023
8 d early
2022
30 d late
2021
31 d late
2020
10 d early
2019
52 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€233k▲ 23.9%
2024 · €188k
2018: €30k
2019: €20k
2020: €40k
2021: €65k
2022: €102k
2023: €151k
2024: €188k
2018 → 2025
Total assets
€958k▲ 3.7%
2024 · €924k
2018: €63k
2019: €569k
2020: €570k
2021: €531k
2022: €525k
2023: €825k
2024: €924k
2018 → 2025
Net result
€45k▲ 22.4%
2024 · €37k
2018: €13k
2019: €-10k
2020: €19k
2021: €26k
2022: €37k
2023: €49k
2024: €37k
2018 → 2025
Working capital
€22k
2024 · €-2k
2018: €25k
2019: €-74k
2020: €-56k
2021: €-32k
2022: €-2k
2023: €-13k
2024: €-2k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€65k-€102k▲ 56.7%€151k▲ 47.9%€188k▲ 24.3%€233k▲ 23.9%
Operating result€47k-€58k▲ 22.7%€74k▲ 29.2%€64k▼ 13.4%€78k▲ 21.8%
Net result€26k-€37k▲ 44.0%€49k▲ 32.2%€37k▼ 24.9%€45k▲ 22.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 22% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €958k
Fixed assets
€847k ▲ 2.7%
Current assets
€111k ▲ 12.4%
Equity and liabilities €958k
Equity
€233k ▲ 23.9%
Debt
€725k ▼ 1.4%
Debt's share of the balance-sheet total falls from 79.6% to 75.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€126k▲
2024 · €106k
Cash flow
€93k▲
2024 · €79k
Current ratio
1.25▲
2024 · 0.98
Debt to equity
3.11▼
2024 · 3.91
ROE
19.3%▼
2024 · 19.5%
ROA
4.7%▲
2024 · 4.0%
Interest coverage
6.26▲
2024 · 6.21
Debt ≤ 1 year
€89k▼
2024 · €101k
Debt > 1 year
€634k▼
2024 · €635k
Income taxes
€18k▲
2024 · €14k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€924k€958k▲
Fixed assets21/28€825k€847k▲
Tangible fixed assets22/27€825k€847k▲
Land and buildings22€649k€811k▲
Furniture and vehicles24€51k€36k▼
Other tangible fixed assets26€186€93▼
Assets under construction and advance payments27€125k-
Current assets29/58€99k€111k▲
Amounts receivable after more than one year29€8k€2k▼
Other amounts receivable291€8k€2k▼
Amounts receivable within one year40/41€52k€87k▲
Trade receivables40-€480
Other amounts receivable41€52k€86k▲
Cash at bank and in hand54/58€37k€19k▼
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€924k€958k▲
Equity10/15€188k€233k▲
Contributions10/11€12k€12k=
Reserves13€166k€211k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€165k€209k▲
Profit (loss) carried forward14€9k€9k▲
Amounts payable17/49€736k€725k▼
Amounts payable after more than one year17€635k€634k▼
Financial debts170/4€635k€634k▼
Amounts payable within one year42/48€101k€89k▼
Current portion of amounts payable after more than one year42€54k€65k▲
Trade debts44€17k€2k▼
Suppliers440/4€17k€2k▼
Taxes, remuneration and social security45€26k€21k▼
Taxes450/3€26k€21k▼
Other amounts payable47/48€3k€870▼
Accrued charges and deferred income492/3-€2k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€42k€48k▲
Other operating charges640/8€4k€4k▼
Gross operating margin9900€110k€130k▲
Operating profit (loss)9901€64k€78k▲
Financial income75/76B€4k€4k▲
Recurring financial income75€4k€4k▲
Financial charges65/66B€17k€20k▲
Recurring financial charges65€17k€20k▲
Profit (loss) for the period before taxes9903€51k€63k▲
Income taxes67/77€14k€18k▲
Profit (loss) for the period9904€37k€45k▲
Profit (loss) for the period to be appropriated9905€37k€45k▲
Appropriation of the result
Profit (loss) to be appropriated9906€46k€54k▲
Profit (loss) brought forward from the previous period14P€9k€9k▲
Transfer to equity691/2€37k€45k▲
To other reserves6921€37k€45k▲
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Equity above €200kEq €233k ▲23.9%
6 profitable years in a row build equity to €233k.
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
23-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2018net €49k ▲32.2%
Net result €49k, the highest in the series.
31-12
Financial
Equity above €150kEq €151k ▲47.9%
4 profitable years in a row build equity to €151k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
31-12
Financial
Equity above €100kEq €102k ▲56.7%
3 profitable years in a row build equity to €102k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
21-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Back to profitnet €19k
Net result €19k after one loss-making year.
21-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 52 days late
Show earlier events
2019
31-12
Financial
Weakest financial yearnet €-10k ▼174%
Net result drops to €-10k, the lowest in the series; recovery starts the following year.
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 28 days late
2018
16-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 16 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Profondeville · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Bois-de-Graux(LV) 755170 ProfondevilleGround area
1,488 m²
Building footprint
112 m²
Volume, LiDAR
786 m³
Parcel 92071D0559/00C000, Wallonia · tallest building 8.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMANUT
since 20172.265.044.426
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92071D0559/00C000 | Wallonia | 1,488 m² | 1 · 112 m² | 8.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Powerbee
BE 0801.456.758
Brussel · Eq €232,920
TDV SERVICES
BE 0803.446.446
Lokeren · Eq €232,913
Divitiae
BE 0560.750.268
Zedelgem · Eq €232,968
AnyWoW
BE 0673.997.768
Lasne · Eq €232,971
F.A.M.O
BE 0894.791.643
Awans · Eq €232,879
Of 82,562 companies in sector 70200 we hold annual accounts for 52,574. 39,214 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-04-2017
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.